BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29090459)

  • 1. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Mohammady M; Janani L; Akbari Sari A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008077. PubMed ID: 29090459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Mohammady M; Janani L; Akbari Sari A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD008077. PubMed ID: 28965359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Mohammady M; Radmehr M; Janani L
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD008077. PubMed ID: 34101161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity.
    Akbari Sari A; Janani L; Mohammady M; Nedjat S
    Cochrane Database Syst Rev; 2014 Jul; (7):CD008077. PubMed ID: 25036897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of low-molecular-weight heparin injection sites on local bruising and pain: A systematic review and meta-analysis.
    Li Y; Dong S; Wang P; Sun J; Jiang H; Liu F
    J Clin Pharm Ther; 2021 Jun; 46(3):688-697. PubMed ID: 33325109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Jones LE
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Cold Application on Bruising and Pain Following Heparin Subcutaneous Injection: A Systematic Review and Meta-Analysis.
    Mohammady M; Sadeghi N
    J Nurs Scholarsh; 2020 Nov; 52(6):634-642. PubMed ID: 32886867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Zorzela LM; Perini E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007557. PubMed ID: 28431186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the effect of the duration of subcutaneous heparin injection on bruising and pain.
    Zaybak A; Khorshid L
    J Clin Nurs; 2008 Feb; 17(3):378-85. PubMed ID: 17931375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study.
    Palese A; Aidone E; Dante A; Pea F
    J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of duration of pressure on bruising and pain in the subcutaneous heparin injection site.
    Yılmaz D; Düzgün F; Durmaz H; Çinar HG; Dikmen Y; Kara H
    Jpn J Nurs Sci; 2020 Jul; 17(3):e12325. PubMed ID: 32022408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins.
    Paravastu SC; Horne M; Dodd PD
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010878. PubMed ID: 27898181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity.
    Vázquez-Calatayud M; Alonso-Fernández S
    Enferm Intensiva (Engl Ed); 2020; 31(3):154-156. PubMed ID: 32682635
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin.
    Chan H
    J Adv Nurs; 2001 Sep; 35(6):882-92. PubMed ID: 11555036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.